cbdMD, Inc. announced that T. Ronan Kennedy, the Company?s Chief Executive Officer and Chief Financial Officer, has been appointed to its Board of Directors. The appointment became effective on December 18, 2024, expanding the board to five members. Ronan Kennedy brings a wealth of expertise in financial management and operational transformation.
Since assuming his leadership role, he has been instrumental in driving cbdMD?s turnaround strategy, achieving substantial cost savings, improving profitability metrics, and laying the groundwork for future growth across its core and emerging product categories.